CRISPR patents, potentially worth billions, belong to Broad Institute – The Verge
Boston Business Journal |
CRISPR patents, potentially worth billions, belong to Broad Institute
The Verge The disputed patents on the gene-editing tool CRISPR belong to the Broad Institute of MIT and Harvard, according to a ruling by judges at the United States Patent and Trademark Office (PTO) in Alexandria, Virginia. The ruling comes a little over two … Patent Office Hands Win in CRISPR Battle to Broad Institute Broad Institute prevails in heated dispute over CRISPR patents Patent office determines UC, Broad Institute patent claims on CRISPR-Cas9 genome editing are separately patentable |
